Cargando…

The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma

To investigate the incidence and outcome of major complication following conventional transarterial embolization/chemoembolization (TAE/TACE) therapy for hepatocellular carcinoma (HCC). From May 2010 to May 2016, all patients with major complication following conventional TAE/TACE for HCC were inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tu, Jianfei, Jia, Zhongzhi, Ying, Xihui, Zhang, Dengke, Li, Shaoqin, Tian, Feng, Jiang, Guomin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266057/ https://www.ncbi.nlm.nih.gov/pubmed/27930585 http://dx.doi.org/10.1097/MD.0000000000005606

Ejemplares similares

Combination therapy: Meta-analysis of the effects of TACE and cryoablation on hepatocellular carcinoma
por: Yuan-Dong, Sun, et al.
Publicado: (2019)

TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma
por: Huang, Dexiao, et al.
Publicado: (2017)

Nomogram for individualized prediction of recurrence after postoperative adjuvant TACE for hepatitis B virus-related hepatocellular carcinoma
por: Jiang, Jiang, et al.
Publicado: (2017)

Microvascular invasion may be the determining factor in selecting TACE as the initial treatment in patients with hepatocellular carcinoma
por: Jeong, Joonho, et al.
Publicado: (2021)

HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Junguo, et al.
Publicado: (2022)

Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
por: Comito, Tiziana, et al.
Publicado: (2022)

Dexamethasone prevents TACE-induced adverse events: A meta-analysis
por: Chang, Lei, et al.
Publicado: (2020)

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome
por: Liu, Weiwen, et al.
Publicado: (2020)

The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma
por: Tseeleesuren, Duurenjargal, et al.
Publicado: (2022)

Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Lawson, Alexander, et al.
Publicado: (2023)

Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma
por: Tu, Jian-Fei, et al.
Publicado: (2016)

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results
por: Hu, Shibing, et al.
Publicado: (2016)

Significant Shrinkage of Multifocal Liver Metastases and Long-Term Survival in a Patient With Rectal Cancer, After Trans-Arterial Chemoembolization (TACE): A Case Report
por: Suciu, Bogdan Andrei, et al.
Publicado: (2015)

A comprehensive intervention on feasibility, efficacy, and safety between TAE combined with multi-applicator ablation therapy and TACE in the treatment of large hepatocellular carcinoma
por: Mahara, Gehendra, et al.
Publicado: (2020)

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery
por: Shen, Tao, et al.
Publicado: (2017)

The Classification and Management Strategy of Spontaneous Isolated Superior Mesenteric Artery Dissection
por: Jia, Zhongzhi, et al.
Publicado: (2017)

A simple prognostic score system predicts the prognosis of solitary large hepatocellular carcinoma following hepatectomy
por: Shen, Jun-yi, et al.
Publicado: (2016)

The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis
por: Rong, Xiaoxiang, et al.
Publicado: (2015)

The Effects of Different Preoperative Biliary Drainage Methods on Complications Following Pancreaticoduodenectomy
por: Huang, Xin, et al.
Publicado: (2015)

Assessing the incidence of complications and malignancies in the long-term management of benign biliary strictures with a percutaneous transhepatic drain
por: Yoshitomi, Munehiro, et al.
Publicado: (2022)

Combined transjugular/percutaneous intrahepatic portosystemic shunts (cTIPS) for cavernous transformation of the portal vein after conventional transjugular approach TIPS failure
por: Bi, Yonghua, et al.
Publicado: (2023)

Drug-eluting bead transarterial chemoembolization (TACE) vs conventional TACE in treating hepatocellular carcinoma patients with multiple conventional TACE treatments history: A comparison of efficacy and safety
por: Li, Hui, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte and aspartate-to-alanine aminotransferase ratios predict hepatocellular carcinoma prognosis after transarterial embolization
por: Liu, Chang, et al.
Publicado: (2017)

Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016)

The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases
por: Vogl, Thomas J., et al.
Publicado: (2022)

Surgical treatment of acute calculous cholecystitis complicated with hepatic dysfunction
por: Tian, Yuanhu, et al.
Publicado: (2020)

The value of conventional manometry in the identification of normal esophageal manometry
por: Bilgin, Serkan, et al.
Publicado: (2021)

Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival
por: Jin, Chen, et al.
Publicado: (2017)

Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection
por: He, Chao, et al.
Publicado: (2017)

A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article
por: Fu, Yi-Peng, et al.
Publicado: (2016)

A Scoring System to Predict the Risk of Postoperative Complications After Laparoscopic Gastrectomy for Gastric Cancer Based on a Large-Scale Retrospective Study
por: Huang, Chang-Ming, et al.
Publicado: (2015)

Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
por: Chang, Pi-Yi, et al.
Publicado: (2023)

Duodenal perforation and esophageal ischemia following transarterial chemoembolization for hepatocellular carcinoma: A case report
por: Kim, Shin Il, et al.
Publicado: (2016)

Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort)
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2020)

Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up
por: Zhang, Wei, et al.
Publicado: (2017)

Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma
por: He, Chao, et al.
Publicado: (2017)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection
por: Zhu, Ying, et al.
Publicado: (2017)

A novel approach to distinguish complicated and non-complicated acute cholecystitis: Decision tree method
por: Gojayev, Afig, et al.
Publicado: (2023)

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis
por: Lan, Tian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n0li48rvt4u3icobunh76n0hce